ScreenerHero
RJFLABORATORIO REIG JOFRE, S.A.
BME · ES · Healthcare · Drug Manufacturers - Specialty & Generic · reigjofre.com
2.680EUR+0.37%Mkt Cap: 238.18M $P/E: 33.38

Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products, raw materials, biotechnological products, nutritional supplements, health products, medical…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
MERCK Kommanditgesellschaft auf Aktien
$65.24BUSDP/E 23.7
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$43.41BUSDP/E 20.1
ZOE
Zoetis Inc.
$29.37BUSDP/E 12.4
UTHR
United Therapeutics Corporation
$22.70BUSDP/E 19.0
VTRS
Viatris, Inc.
$18.66BUSD
SOBI
Swedish Orphan Biovitrum AB
$15.39BUSDP/E 118.0
NBIX
Neurocrine Biosciences, Inc.
$15.81BUSDP/E 22.8
IPN
Ipsen S.A.
$14.67BUSDP/E 26.5
ELAN
Elanco Animal Health Incorporat
$12.24BUSD
KRK
Krka, d. d.
$8.57BUSDP/E 18.8
HIMS
Hims & Hers Health, Inc.
$7.25BUSD
LQDA
Liquidia Corporation
$6.74BUSDP/E 53.8
LNTH
Lantheus Holdings Inc
$6.56BUSDP/E 24.0
AMRX
Amneal Pharmaceuticals, Inc.
$6.23BUSDP/E 37.3
INDV
Indivior PLC Ordinary Shares
$4.61BUSDP/E 14.0
HIK
Hikma Pharmaceuticals PLC
$4.32BUSDP/E 12.5
AMLX
Amylyx Pharmaceuticals Inc. Common Stock
$4.30BUSD
SFZN
Siegfried Holding AG
$3.91BUSDP/E 20.4
ROVI
Laboratorios Farmaceuticos Rovi, S.A.
$3.34BUSDP/E 16.6
SUPN
Supernus Pharmaceuticals, Inc.
$2.82BUSD

Key Statistics

Company
Market Cap238.18M $
Enterprise Value351.52M $
Revenue (TTM)367.10M $
Gross Profit212.88M $
Net Income (TTM)5.46M $
Revenue/Share4.497 USD
Last Price2.680 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees1.5K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0165359029
Valuation
P/E (Trailing)33.38
P/E (Forward)22.17
PEG0.34
EV/EBITDA13.42
EV/Revenue0.96
P/S—
P/B0.99
EPS (TTM)0.08
EPS (Forward)0.12
52W Range
2.32035% of range3.350
52W High3.350 EUR
52W Low2.320 EUR
Profitability
Gross Margin59.15%
Oper. Margin1.82%
EBITDA Margin7.14%
Profit Margin1.52%
ROE2.30%
ROA1.27%
Growth
Revenue Growth1.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.65M $
CapEx (TTM)19.90M $
FCF Margin—
FCF Yield—
Net Debt113.55M $
Net Debt/EBITDA4.33
Balance Sheet
Debt/Equity0.42
Current Ratio1.51
Quick Ratio0.80
Book Value/Sh2.679 EUR
Cash/Share0.1860 EUR
Dividends
Fwd Div Rate0.0200 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.90%
5Y Avg Yield1.52%
Payout Ratio30.00%
Ex-Div DateMay 21, 2026
Pay Date—
Splits
Last Split1:20
Split DateSep 22, 2015
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.82.07M
Float21.47M
Insiders78.46%
Institutions6.82%
Technical
SMA 502.674 (+0.2%)
SMA 2002.663 (+0.6%)
Beta0.95
S&P 52W Chg18.16%
Avg Vol (30d)7.46K
Avg Vol (10d)4.58K
Technical Indicators
RSI (14)47.3
MACD-0.0039
MACD Signal0.0008
MACD Hist.-0.0046
BB Upper2.749 EUR
BB Middle2.687 EUR
BB Lower2.625 EUR
BB Width4.64%
ATR (14)0.0384 EUR
Vol Ratio (20d)0.15x